We found that lead exposure specifically promotes NF2-wildtype meningioma cell proliferation and increases cell size, but has no effect on NF2-null meningioma cells, further confirming that a critical role for Merlin in mediating the effects induced by lead treatment (Fig. 1, 2, 7). The gene discussed is NF2; the disease is meningioma.